SecSonar.com

ImageneBio Inc (IMA)

ImageneBio Inc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ImageneBio Inc (IMA) is a Biotechnology company based in US with a market capitalization of $65.9M. Revenue declined 77.1% year-over-year and free cash flow was negative at -$47.8M. This page tracks IMA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 10 employees · IPO Feb 27, 1998

Valuation

Valuation & price

$5.68 · as of May 17, 2026 · -68.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.50

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$17.90$11.32$4.75Jul 25Dec 25Jul 26Jul 7, 25$16.20Jul 9, 25$16.08Jul 11, 25$16.56Jul 15, 25$17.04Jul 17, 25$15.12Jul 21, 25$15.24Jul 23, 25$16.56Jul 25, 25$17.16Jul 29, 25$15.20Jul 31, 25$17.90Aug 4, 25$16.60Aug 6, 25$15.75Aug 11, 25$14.74Aug 13, 25$14.20Aug 15, 25$14.20Aug 19, 25$14.04Aug 21, 25$14.08Aug 25, 25$14.15Aug 27, 25$13.64Aug 29, 25$13.40Sep 3, 25$13.72Sep 5, 25$7.96Sep 9, 25$9.19Sep 11, 25$9.20Sep 16, 25$8.52Sep 18, 25$8.35Sep 22, 25$8.00Sep 24, 25$8.00Sep 26, 25$7.71Sep 30, 25$8.15Oct 2, 25$8.64Oct 6, 25$8.61Oct 8, 25$8.27Oct 10, 25$7.96Oct 14, 25$7.64Oct 16, 25$7.59Oct 21, 25$7.48Oct 23, 25$7.39Oct 27, 25$8.35Oct 29, 25$8.79Oct 31, 25$8.71Nov 4, 25$8.24Nov 6, 25$8.39Nov 10, 25$8.20Nov 12, 25$8.55Nov 14, 25$8.16Nov 18, 25$7.63Nov 20, 25$7.15Nov 25, 25$7.25Nov 28, 25$6.90Dec 2, 25$6.21Dec 4, 25$6.78Dec 8, 25$6.54Dec 10, 25$6.43Dec 12, 25$6.50Dec 16, 25$6.25Dec 18, 25$6.19Dec 22, 25$5.98Dec 24, 25$5.85Dec 29, 25$6.41Jan 2, 26$6.76Jan 6, 26$6.62Jan 8, 26$6.85Jan 12, 26$6.90Jan 14, 26$6.83Jan 16, 26$6.53Jan 21, 26$7.10Jan 23, 26$7.22Jan 27, 26$7.35Jan 29, 26$7.33Feb 2, 26$7.09Feb 4, 26$7.02Feb 9, 26$7.36Feb 11, 26$7.02Feb 13, 26$6.91Feb 18, 26$6.54Feb 20, 26$7.00Feb 24, 26$6.64Feb 26, 26$6.83Mar 2, 26$6.37Mar 4, 26$6.15Mar 6, 26$5.84Mar 10, 26$6.07Mar 12, 26$6.00Mar 17, 26$6.02Mar 19, 26$5.69Mar 23, 26$5.63Mar 25, 26$5.56Mar 27, 26$5.00Mar 31, 26$5.00Apr 2, 26$4.97Apr 7, 26$4.75Apr 9, 26$4.75Apr 13, 26$6.05Apr 15, 26$5.65Apr 17, 26$5.90Apr 22, 26$6.01Apr 24, 26$5.71Apr 28, 26$5.75Apr 30, 26$6.02May 4, 26$5.72May 6, 26$6.08May 8, 26$5.29May 12, 26$5.72May 14, 26$5.91May 18, 26$5.65May 20, 26$5.41May 22, 26$5.56May 28, 26$5.93Jun 1, 26$5.47Jun 3, 26$5.45Jun 5, 26$5.65Jun 9, 26$5.55Jun 11, 26$5.71Jun 15, 26$5.54Jun 17, 26$5.69Jun 22, 26$5.99Jun 24, 26$6.00Jun 26, 26$6.02Jul 2, 26$5.83
$4.5552-week range$17.90
Loading valuation history…

Fundamentals

Key fundamentals

$65.9M

Market cap

-77.1%

Revenue growth (YoY)

-29.1%

Gross margin

-$47.8M

Free cash flow (USD)

-$65.8M

Net debt

Net cash position

-89.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$990.0KFY 2019$13.8MFY 2020$9.2MFY 2021$31.0MFY 2022$15.6MFY 2023$9.2MFY 2024$3.5MFY 2025$800.0K
$990K$800K

Free cash flow by year

2018 → 2025

FY 2018$-11.9MFY 2019$47.6MFY 2020$-38.6MFY 2021$-62.0MFY 2022$-75.5MFY 2023$-80.2MFY 2024$-46.0MFY 2025$-47.8M
-$11.9M-$47.8M

Gross margin by year

2021 → 2025

FY 2021-52.0%FY 2022-311.8%FY 202388.9%FY 2024100.0%FY 2025-29.1%
-52.0%-29.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventExecutive ResignationJun 26, 2026Filing
  • 8-K eventEquity Incentive Plan AmendedJun 17, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventSecurities Purchase AgreementApr 13, 2026Filing

Questions

Frequently asked questions

What is ImageneBio Inc's market cap?

ImageneBio Inc (IMA) has a market capitalization of $65.9M.

What is IMA's P/E ratio?

A meaningful P/E ratio is not available for IMA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IMA's price-to-book (P/B) ratio?

IMA trades at 0.50 times book value per share.

Are insiders buying IMA stock?

SEC Form 4 filings show no open-market insider buys at ImageneBio Inc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

MNOV

MediciNova, Inc.

$66M

CBUS

Cibus, Inc.

$66.6M

IMMP

Immutep Limited

$65M

TCRX

TScan Therapeutics, Inc.

$67.2M

CLNN

Clene Inc.

$67.7M

VRCA

Verrica Pharmaceuticals Inc.

$64.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.